Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/8/2021
Allecra and Haini Pharma Enter Licensing Deal for Cefepime/Enmetazob...
1/8/2021
Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...
1/8/2021
HLB's Liver Cancer Drug Wins Marketing Approval in China
1/8/2021
Abbisko Raises $123 Million From Carlyle, Warburg
1/8/2021
European Firms Eye Chinese Assets in Mainly Insurance and Healthcare...
1/8/2021
Recent Executive Moves
1/8/2021
SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...
1/8/2021
S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...
1/7/2021
Economic Burden and Health Care Access for Patients with IBD in China:...
1/7/2021
China Issues Announcement on the 2021 Doping List (#51)
1/7/2021
Apollomics Granted Breakthrough Therapy Designation for AML Drug APL-1...
1/6/2021
NHC Issues Two New Documents on Public Hospital Management
1/6/2021
Eli Lilly Granted Chinese Approval of Verzenio (Abemaciclib)
1/6/2021
Immedica and Winhealth Sign Deal for UCD Drug Ravicti in Greater Chin...
1/6/2021
25 Domestics Filed 96 ANDAs in the U.S. in 2020
1/6/2021
Argenx and Zai Lab Enter Strategic Deal for Efgartigimod in Greater Ch...
1/6/2021
Winhealth Pharma and TWiB Enter into Strategic Licensing Partnership o...
1/5/2021
NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
1/5/2021
Harbour BioMed Completes Its Global Offering and Listing on the HKSE
1/5/2021
Terns Pharma Raises $87M in Series C Funding to Get NASH Hopefuls Thru
1/5/2021
Chipscreen's Chiauranib Granted Breakthrough Therapy Designation in Ch...
1/4/2021
NMPA Signs MOU on Regulatory Cooperation with Italian Medicines Agenc...
1/4/2021
CDE Introduces Numerous Technical Guidelines
1/4/2021
Inovio Partners with Advaccine to Make and Sell Covid-19 Vaccine in Ch...
1/4/2021
Shanghai Pharma Breaks Ground on $1.8B Biotech Park Focused on Next-ge...
12/31/2020
CDE Issues the Measures for Transparency of Drug Evaluation and Approv...
12/31/2020
Data Analysis of Chinese Healthcare Spending and BMI System Finance 20...
12/31/2020
Financial-related Company News in Brief
12/31/2020
China Appears to Open Wider to Innovative Medicines as It Intensify He...
12/30/2020
NMPA Issues the List of Reference Formulations for GQCE Studies (35th ...
Page:
149
/
719
Total number of articles:
21555
:
[First]
[<<]
[147]
[148]
[149]
[150]
[151]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit